1/1
3 files

Totality of Evidence Supporting the Use of ABP 980, a Trastuzumab Biosimilar: Practical Considerations

media
posted on 14.01.2021, 11:41 by Hans-Christian Kolberg, Georgia Savva Demetriou, Vladimir Hanes

Article full text


The above summary slide and videos represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.

History

Exports